A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NCT06270706 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumor

Interventions

DRUG: PLN-101095
DRUG: PLN-101095
DRUG: PLN-101095
DRUG: PLN-101095
DRUG: PLN-101095
DRUG: PLN-101095
DRUG: Pembrolizumab

Sponsor

Pliant Therapeutics, Inc.